DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Study of T-PRED(TM) Compared to Pred Forte(R)

Information source: Bausch & Lomb Incorporated
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cataract

Intervention: T-PRED (Drug); T-PRED (Drug); Pred Forte (Drug); Pred Forte (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: Bausch & Lomb Incorporated

Official(s) and/or principal investigator(s):
Tim McNamara, PharmD, Study Director, Affiliation: ISTA Pharmaceuticals, Inc.


Study of T-PRED(TM) compared to Pred Forte(R)

Clinical Details

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science

Primary outcome: Ratio of means aqueous humor prednisolone acetate concentrations


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- 18 years of age

Exclusion Criteria:

- No active or adverse disease

Locations and Contacts

ISTA Pharmaceuticals, Inc., Irvine, California 92618, United States
Additional Information

Starting date: May 2008
Last updated: April 4, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017